Gyaw S - Search Results

1

Results of a randomized, double-blind, placebo-controlled trial of lorcaserin in cocaine use disorder.

McCann DJ, Chen HH, Devine EG, Gyaw S, Ramey T. McCann DJ, et al. Among authors: gyaw s. Drug Alcohol Depend. 2024 Feb 1;255:111063. doi: 10.1016/j.drugalcdep.2023.111063. Epub 2023 Dec 17. Drug Alcohol Depend. 2024. PMID: 38163425 Clinical Trial.

2

Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence.

Gilgun-Sherki Y, Eliaz RE, McCann DJ, Loupe PS, Eyal E, Blatt K, Cohen-Barak O, Hallak H, Chiang N, Gyaw S. Gilgun-Sherki Y, et al. Among authors: gyaw s. Drug Alcohol Depend. 2016 Sep 1;166:13-20. doi: 10.1016/j.drugalcdep.2016.05.019. Epub 2016 May 28. Drug Alcohol Depend. 2016. PMID: 27394932 Free article. Clinical Trial.

3

Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA-Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device.

Krieter PA, Chiang CN, Gyaw S, McCann DJ. Krieter PA, et al. Among authors: gyaw s. J Clin Pharmacol. 2019 Aug;59(8):1078-1084. doi: 10.1002/jcph.1401. Epub 2019 Mar 12. J Clin Pharmacol. 2019. PMID: 30861160 Free PMC article. Clinical Trial.

4

Enhanced Intranasal Absorption of Naltrexone by Dodecyl Maltopyranoside: Implications for the Treatment of Opioid Overdose.

Krieter P, Gyaw S, Chiang CN, Crystal R, Skolnick P. Krieter P, et al. Among authors: gyaw s. J Clin Pharmacol. 2019 Jul;59(7):947-957. doi: 10.1002/jcph.1384. Epub 2019 Jan 30. J Clin Pharmacol. 2019. PMID: 30698833 Free PMC article.

5

Pharmacokinetic Interaction between Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects.

Krieter P, Chiang CN, Gyaw S, Skolnick P, Snyder R. Krieter P, et al. Among authors: gyaw s. Drug Metab Dispos. 2019 Jul;47(7):690-698. doi: 10.1124/dmd.118.085977. Epub 2019 Apr 16. Drug Metab Dispos. 2019. PMID: 30992306 Free PMC article. Clinical Trial.

6

Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.

Krieter P, Chiang N, Gyaw S, Skolnick P, Crystal R, Keegan F, Aker J, Beck M, Harris J. Krieter P, et al. Among authors: gyaw s. J Clin Pharmacol. 2016 Oct;56(10):1243-53. doi: 10.1002/jcph.759. Epub 2016 Jun 10. J Clin Pharmacol. 2016. PMID: 27145977

7

Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.

Krieter P, Gyaw S, Crystal R, Skolnick P. Krieter P, et al. Among authors: gyaw s. J Pharmacol Exp Ther. 2019 Nov;371(2):409-415. doi: 10.1124/jpet.118.256115. Epub 2019 Apr 2. J Pharmacol Exp Ther. 2019. PMID: 30940694 Free PMC article. Clinical Trial.

8

Pneumomediastinum: the Valsalva crunch.

Shyamsunder AK, Gyaw SM. Shyamsunder AK, et al. Among authors: gyaw sm. Md Med J. 1999 Nov-Dec;48(6):299-302. Md Med J. 1999. PMID: 10628131

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page